SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-018497
Filing Date
2024-05-09
Accepted
2024-05-09 17:05:14
Documents
14
Period of Report
2024-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39028
2 ex99-1.htm EX-99.1 110027
  Complete submission text file 0001493152-24-018497.txt   333793

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE aztr-20240509.xsd EX-101.SCH 3018
4 XBRL LABEL FILE aztr-20240509_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE aztr-20240509_pre.xml EX-101.PRE 22361
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3808
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

IRS No.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41705 | Film No.: 24931764
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)